These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of Yu HN; Liu L; Chen QS; He Q; Li YS; Wang Y; Gao S Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632 [TBL] [Abstract][Full Text] [Related]
6. Reports of 17 Chinese patients with tumor-induced osteomalacia. Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966 [TBL] [Abstract][Full Text] [Related]
8. Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1. Albers MB; Librizzi D; Lopez CL; Manoharan J; Apitzsch JC; Slater EP; Bollmann C; Kann PH; Bartsch DK World J Surg; 2017 Jun; 41(6):1521-1527. PubMed ID: 28138732 [TBL] [Abstract][Full Text] [Related]
9. Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia. Long T; Hou J; Yang N; Zhou M; Li Y; Li J; Tang Y; Chen D; Hu S J Clin Endocrinol Metab; 2021 Sep; 106(10):e4202-e4209. PubMed ID: 33864458 [TBL] [Abstract][Full Text] [Related]
10. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT. Breer S; Brunkhorst T; Beil FT; Peldschus K; Heiland M; Klutmann S; Barvencik F; Zustin J; Gratz KF; Amling M Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333 [TBL] [Abstract][Full Text] [Related]
11. Li J Front Endocrinol (Lausanne); 2024; 15():1400751. PubMed ID: 38887276 [TBL] [Abstract][Full Text] [Related]
12. Increased Activity Due to Fractures Does Not Significantly Affect the Accuracy of 68Ga-DOTATATE PET/CT in the Detection of Culprit Tumor in the Evaluation of Tumor-Induced Osteomalacia. Ding J; Hu G; Wang L; Li F; Huo L Clin Nucl Med; 2018 Dec; 43(12):880-886. PubMed ID: 30273206 [TBL] [Abstract][Full Text] [Related]
14. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Frilling A; Sotiropoulos GC; Radtke A; Malago M; Bockisch A; Kuehl H; Li J; Broelsch CE Ann Surg; 2010 Nov; 252(5):850-6. PubMed ID: 21037441 [TBL] [Abstract][Full Text] [Related]
15. [Value of Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385 [TBL] [Abstract][Full Text] [Related]
16. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management. Singh D; Chopra A; Ravina M; Kongara S; Bhatia E; Kumar N; Gupta S; Yadav S; Dabadghao P; Yadav R; Dube V; Kumar U; Dixit M; Gambhir S Br J Radiol; 2017 Apr; 90(1072):20160811. PubMed ID: 28181822 [TBL] [Abstract][Full Text] [Related]
17. Additional information gained by positron emission tomography with (68)Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors. Nakamoto Y; Sano K; Ishimori T; Ueda M; Temma T; Saji H; Togashi K Ann Nucl Med; 2015 Jul; 29(6):512-8. PubMed ID: 25894056 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia. Agrawal K; Bhadada S; Mittal BR; Shukla J; Sood A; Bhattacharya A; Bhansali A Clin Nucl Med; 2015 Jan; 40(1):e6-e10. PubMed ID: 24999675 [TBL] [Abstract][Full Text] [Related]
19. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors. Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C Recent Results Cancer Res; 2013; 194():353-71. PubMed ID: 22918768 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance. Fanchon LM; Dogan S; Moreira AL; Carlin SA; Schmidtlein CR; Yorke E; Apte AP; Burger IA; Durack JC; Erinjeri JP; Maybody M; Schöder H; Siegelbaum RH; Sofocleous CT; Deasy JO; Solomon SB; Humm JL; Kirov AS J Nucl Med; 2015 Apr; 56(4):538-44. PubMed ID: 25722446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]